Repligen CorporationRGEN
NasdaqGS•Healthcare•Medical Instruments & Supplies
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $763.34M, growing 17.0% year-over-year. TTM net income stood at $51.40M (336.0% growth). Quarterly EBITDA was $35.70M and operating income was $15.94M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze RGEN growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters